Skip to main content
Log in

Immunisation and Type 1 Diabetes Mellitus

Is There a Link?

  • Current Opinion
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Recent evidence from animal studies has raised the possibility that immunisation by vaccines can influence the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. In non-obese diabetic mice and biobreeding rats, complete Freund’s adjuvant and bacillus Calmette-Guérin (BCG) vaccine have successfully been used to interrupt the development of diabetes mellitus. This effect is probably mediated by nonspecific suppression of the autoimmune process. A number of attempts have also been made to assess the impact of parenteral immunisation on type 1 diabetes mellitus in humans.

Epidemiological evidence has not indicated any clear link between BCG vaccination and the development of diabetes mellitus in humans. Some reports have suggested that natural mumps or mumps vaccinations can induce islet cell auto-immunity, but there is no evidence that mumps-measles-rubella mass vaccination programmes have changed the incidence of diabetes mellitus in any population. An independent protective role of measles virus has been suggested in one study. Recent studies have indicated that enterovirus infections may induce β cell auto-immunity and clinical diabetes. The only currently available enterovirus vaccine is the poliovirus vaccine which, in theory, could modulate the protection against other enteroviruses by inducing cross-reactive T cell immune responses; however, this hypothesis has not been tested so far.

In conclusion, there is no clear evidence that any currently used vaccine can prevent or induce diabetes in humans. However, only a few studies are available on the subject and therefore the possibility of a link between vaccination and diabetes mellitus cannot be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Karvonen M, Tuomilehto J, Libman I. The World Health Organisation DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 833–92

    Article  Google Scholar 

  2. Rewers M, Atkinson M. The possible role of enteroviruses in diabetes mellitus. In: Rotbart HA, editor. Human enterovirus infections. Washington (DC): American Society for Microbiology, 1995: 353–85

    Google Scholar 

  3. Vardi P. Adjuvant administration modulates the process of beta-cell autoimmunity and prevents IDDM: introduction to human trials. Diabetes Metab Rev 1993; 9: 317–22

    Article  PubMed  CAS  Google Scholar 

  4. Sadelain MWJ, Qin H-Y, Lauzon J, et al. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39: 583–9

    Article  PubMed  CAS  Google Scholar 

  5. Harada M, Kishimoto Y, Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 1990; 8: 85–89

    Article  PubMed  CAS  Google Scholar 

  6. Yagi H, Matsumoto M, Kishimoto Y, et al. Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse: II: suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice. Cell Immunol 1991; 138: 142–9

    Article  PubMed  CAS  Google Scholar 

  7. Wang T, Singh B, Warnock GL, et al. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant therapy. Diabetes 1992; 41: 114

    Article  PubMed  CAS  Google Scholar 

  8. Lakey JRT, Singh B, Warnock GL, et al. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation 1994; 57: 1213–7

    Article  PubMed  CAS  Google Scholar 

  9. Baxter AG, Horsfall AC, Healey D, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994; 83: 227–31

    PubMed  CAS  Google Scholar 

  10. Gazda L, Baxter AG, Lafferty KJ. Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol Cell Biol 1996; 74: 401–7

    Article  PubMed  CAS  Google Scholar 

  11. Qin H Y, Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophophamide. J Autoimmun 1997; 10: 271–8

    Article  PubMed  CAS  Google Scholar 

  12. Huang S-W, Taylor G, Basid A. The effect of pertussigen vaccine on the insulin-dependent diabetes induced by streptozotocin in mice. Pediatr Res 1984; 18: 221–6

    Article  PubMed  CAS  Google Scholar 

  13. Huang S-W, Luchetta R, Peck AB. Pertussigen treatment retards, but fails to prevent, the development of type 1, insulin-dependent diabetes mellitus (IDDM) in NOD mice. Autoimmunity 1991; 9: 311–7

    Article  PubMed  CAS  Google Scholar 

  14. Ramiya VK, Shang X-Z, Pharis PG, et al. Antigen based therapies to prevent diabetes in NOD mice. J Autoimmun 1996; 9: 349–56

    Article  PubMed  CAS  Google Scholar 

  15. Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996; 24: 137–45

    Article  PubMed  CAS  Google Scholar 

  16. Smerdon RA, Peakman M, Hussain MJ, et al. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 1993; 80: 498–501

    PubMed  CAS  Google Scholar 

  17. Shehadeh N, Calcinaro F, Bradley BJ, et al. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 1994; 343: 706–7

    Article  PubMed  CAS  Google Scholar 

  18. Pozzilli P, IMDIAB Group. BCG vaccine in insulin-dependent diabetes mellitus. Lancet 1997; 349: 1520–1

    Article  PubMed  CAS  Google Scholar 

  19. Dahlquist G, Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination [letter]. Diabetologia 1995; 38: 874

    Article  Google Scholar 

  20. Classen JB, Classsen DC. Vaccines modulate IDDM. Diabetologia 1996; 39: 500–2

    Article  PubMed  CAS  Google Scholar 

  21. Parent M-E, Fritschi L, Siemiatycki J, et al. Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997; 20: 767–72

    Article  PubMed  CAS  Google Scholar 

  22. Sinaniotis CA, Daskalopoulou E, Lapatsanis P, et al. Diabetes mellitus after mumps vaccination [letter]. Arch Dis Child 1975; 50: 749–50

    Article  PubMed  CAS  Google Scholar 

  23. Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection [letter]. Lancet 1980; II: 211–2

    Article  Google Scholar 

  24. Helmke K, Otten A, Willems WR, et al. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 1986; 29: 30–3

    Article  PubMed  CAS  Google Scholar 

  25. Ratzmann KP, Strese J, Witt S, et al. Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care 1984; 7: 170–3

    Article  PubMed  CAS  Google Scholar 

  26. Federlin K, Otten A, Helmke A. Islet cell antibodies and viral infections. Exp Clin Endocrinol 1987; 89: 368–74

    Article  PubMed  CAS  Google Scholar 

  27. Hummel M, Ziegler A-G, BABY-DIAB Study. Vaccines and the appearance of islet cell antibodies in offspring of diabetic parents. Diabetes Care 1996; 19: 1456–7

    PubMed  CAS  Google Scholar 

  28. Hyöty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993; 36: 1303–8

    Article  PubMed  Google Scholar 

  29. Hiltunen M, Hyöty H, Leinikki P, et al. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children. Diabet Med 1994; 11: 942–6

    Article  PubMed  CAS  Google Scholar 

  30. Blom L, Nyström L, Dahlquist G, the Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991; 34: 176–81

    Article  PubMed  CAS  Google Scholar 

  31. Hejbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 1997; 20: 173–5

    Article  Google Scholar 

  32. Hyöty H, Hiltunen M, Knip M, the Childhood Diabetes in Finland (DiMe) Study group. A prospective study of the role of coxsackie B virus and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652–7

    Article  PubMed  Google Scholar 

  33. Hiltunen M, Hyöty H, Knip M, the Childhood Diabetes in Finland (DiMe) Study Group. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175: 554–60

    Article  PubMed  CAS  Google Scholar 

  34. Juhela S, Hyöty H, Lönnrot M, et al. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998; 54: 226–32

    Article  PubMed  CAS  Google Scholar 

  35. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996; 9: 699–703

    Article  PubMed  CAS  Google Scholar 

  36. Singh B. Possible immunological treatment for type 1 diabetes in the 21st century. Pract Diabetes Int 1997; 14: 197–200

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heikki Hyöty.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hiltunen, M., Lönnrot, M. & Hyöty, H. Immunisation and Type 1 Diabetes Mellitus. Drug-Safety 20, 207–212 (1999). https://doi.org/10.2165/00002018-199920030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199920030-00001

Keywords

Navigation